Likewise, edelfosine was able to induce apoptotic death in another two prostate cancer cell lines, LNCaP and VCap, through the differential regulation of p-AKT and activated transcription factor 3 (ATF3), respectively [two known regulators of androgen receptor (AR) activity]. This evidence concerns the gene AR and prostate cancer.